January 14, 2026 11:15 AM
Real-Time Market Data: Dr Reddys Laboratories Ltd Share Price Drops
The stock of Dr Reddys Laboratories Ltd is facing a -0.37% decline and is currently trading at 1186.90 per share. Investors are closely monitoring this situation for potential signs of a turnaround.
January 14, 2026 10:17 AM
Dr Reddys Laboratories Ltd Share Price in Red Today: Decline by -0.37%
The stock of Dr Reddys Laboratories Ltd suffered a -0.37% drop, and it's now trading at 1186.90 per share. Investors are assessing whether this decline represents a buying opportunity or a sign of ongoing challenges.
January 14, 2026 9:17 AM
Dr Reddys Laboratories Ltd Share Price in Red Today
Dr Reddys Laboratories Ltd share price has declined by -0.90%, and it's currently trading at 1180.60. The stock maintains a PE of 17.3200, while the industry PE is 33.0503, prompting discussions about its valuation.
January 14, 2026 8:17 AM
Dr Reddys Laboratories Ltd Stock Slides Today
Dr Reddys Laboratories Ltd observed a -0.36% decrease in its share price, a situation that merits attention. As of now, it's actively trading at 1187.00. The stock has a PE ratio of 17.3200, an ROE of 16.0277 and a debt to equity ratio of 0.1625.
January 14, 2026 7:17 AM
Dr Reddys Laboratories Ltd Tumbles -0.48% in Today's Trading Session
After a -0.48% decline, Dr Reddys Laboratories Ltd shares are now trading at 1185.60. The stock has a PE ratio of 17.3200, an ROE of 16.0277 and a debt to equity ratio of 0.1625.
January 14, 2026 6:17 AM
Dr Reddys Laboratories Ltd Share Price Falls -0.65% in Today's Trading Session
Dr Reddys Laboratories Ltd witnessed a -0.65% drop in its share price and is currently trading at 1183.50. With the stock's PE at 17.3200 and the industry PE at 33.0503, investors are weighing their options.
January 14, 2026 5:16 AM
Today's Trading Session: Dr Reddys Laboratories Ltd Stock Falls
With a -0.33% decrease, Dr Reddys Laboratories Ltd's share price is now at 1187.40. The stock is currently trading at a PE of 17.3200, while the industry PE is 33.0503, prompting investors to assess its value proposition.